Flouzat-Lachaniete Charles Henri, Roussignol Xavier, Poignard Alexandre, Mukasa Martin Mukisi, Manicom Olivier, Hernigou Philippe
Hospital Henri Mondor, 94010 Creteil, France.
Open Orthop J. 2009 May 15;3:32-5. doi: 10.2174/1874325000903010032.
The purpose of this study was to evaluate the frequency of multifocal osteonecrosis in patients with sickle cell disease. Between 1980 and 1989, 200 patients with sickle cell disease were treated in our institution for osteonecrosis. The patient population consisted of 102 males and 88 females with a mean age of twenty-six years at the time of presentation (range, eighteen to thirty-five years) and was followed until the year 2005. This cohort of patients was follow-up during average 15 years (until the year 2005). Multifocal osteonecrosis was defined as a disease of 3 or more anatomic sites. At the time of presentation, 49 patients were identified as having multifocal osteonecrosis. At the most recent follow-up, 87 patients had multifocal osteonecrosis. So at the last follow up among these eighty-seven patients, the occurrence of osteonecrosis was 158 lesions of the proximal femur associated with 151 proximal humerus osteonecroses, thirty-three lateral femoral condyle osteonecroses, twenty-eight distal femoral metaphysis osteonecroses, twenty-seven medial femoral condyle osteonecroses, twenty-three tibial plateau osteonecroses, twenty-one upper tibial metaphysis osteonecroses and forteen ankle osteonecroses. The total number of osteonecrosis was 455 in these 87 patients. The epiphyseal lesions were more frequent than the metadiaphyseal lesions excepted in the proximal tibia (Table 3). In conclusion, in patients with sickle cell disease, the risk of multifocal osteonecrosis is very high. In patients with hip osteonecrosis, the other joints should be evaluated with radiograph and MRI if the joint is symptomatic. In patients with osteonecrosis of the knee, shoulder or ankle, the patients' hip should be evaluated by radiographs or MRI, regardless of whether the hip is symptomatic.
本研究的目的是评估镰状细胞病患者多灶性骨坏死的发生率。1980年至1989年期间,我院对200例镰状细胞病合并骨坏死患者进行了治疗。患者群体包括102名男性和88名女性,就诊时平均年龄为26岁(范围为18至35岁),随访至2005年。这组患者平均随访了15年(至2005年)。多灶性骨坏死定义为累及3个或更多解剖部位的疾病。就诊时,49例患者被确诊为多灶性骨坏死。在最近一次随访时,87例患者患有多灶性骨坏死。在这87例患者的最后一次随访中,骨坏死的发生情况为:158处股骨近端病变伴151处肱骨近端骨坏死、33处股骨外侧髁骨坏死、28处股骨远端干骺端骨坏死、27处股骨内侧髁骨坏死、23处胫骨平台骨坏死、21处胫骨近端干骺端骨坏死和14处踝关节骨坏死。这87例患者的骨坏死总数为455处。除胫骨近端外,骨骺病变比干骺端病变更常见(表3)。总之,镰状细胞病患者发生多灶性骨坏死的风险非常高。对于患有髋部骨坏死的患者,如果其他关节有症状,应通过X线片和磁共振成像(MRI)进行评估。对于患有膝关节、肩关节或踝关节骨坏死的患者,无论髋部是否有症状,均应通过X线片或MRI对其髋部进行评估。